Benign diesease & IBD,Rare disease & stoma
- Prolapse of intestinal stoma
-
Kotaro Maeda
-
Ann Coloproctol. 2022;38(5):335-342. Published online October 28, 2022
-
DOI: https://doi.org/10.3393/ac.2022.00465.0066
-
-
7,479
View
-
263
Download
-
7
Web of Science
-
10
Citations
-
Abstract
PDF
- Stoma prolapse can usually be managed conservatively by stoma care nurses. However, surgical management is considered when complications make traditional care difficult and/or stoma prolapse affects normal bowel function and induces incarceration. If the stoma functions as a fecal diversion, the prolapse is resolved by stoma reversal. Loop stoma prolapse reportedly occurs when increased intraabdominal pressure induces stoma prolapse by pushing the stoma up between the abdominal wall and the intestine, particularly in cases of redundant or mobile colon. Therefore, stoma prolapse repair aims to prevent or eliminate the space between the abdominal wall and the intestine, as well as the redundant or mobile intestine. Accordingly, surgical repair methods for stoma prolapse are classified into 3 types: methods to fix the intestine, methods to shorten the intestine, and methods to eliminate the space between the stoma and the abdominal wall around the stoma orifice. Additionally, the following surgical techniques at the time of stoma creation are reported to be effective in preventing stoma prolapse: an avoidance of excessive fascia incision, fixation of the stoma to the abdominal wall, an appropriate selection of the intestinal site for the stoma orifice to minimize the redundant intestine, and the use of an extraperitoneal route for stoma creation.
-
Citations
Citations to this article as recorded by

- Comprehensive nursing management for an older patient with diarrhoea and risk of dehydration
Tiago Horta Reis da Silva
Gastrointestinal Nursing.2025; 23(2): 89. CrossRef - Incarcerated trans-stomal herniation resembling a stomal prolapse – a case report
N Shaikh, RV Blanco, M Vente, R Ebrahim
South African Journal of Surgery.2025; 63(1): 31. CrossRef - Stoma Complications
Aaron J. Dawes, John V. Gahagan
Clinics in Colon and Rectal Surgery.2024; 37(06): 387. CrossRef - Management of the Difficult Stoma
Clay Merritt, Paola Maldonado
Surgical Clinics of North America.2024; 104(3): 579. CrossRef - Ileostomy: Early and Late Complications
Francisco Duarte Cerqueira Gomes Girão Santos, Laura Elisabete Ribeiro Barbosa, João Paulo Meireles de Araújo Teixeira
Journal of Coloproctology.2024; 44(01): e80. CrossRef - Risk factors for stoma prolapse after laparoscopic loop colostomy
Yusuke Takashima, Hitoshi Hino, Akio Shiomi, Hiroyasu Kagawa, Shoichi Manabe, Yusuke Yamaoka, Chikara Maeda, Shunsuke Kasai, Yusuke Tanaka
Surgical Endoscopy.2024; 38(5): 2834. CrossRef - Linear stapler refashioning technique for irreducible stomal prolapse—A video vignette
Rajesh S. Shinde, Deep Mashru, Murali V
Colorectal Disease.2024; 26(7): 1483. CrossRef - Stomal Prolapse Due to Sidedness of Transverse Loop Colostomy: A Retrospective Cohort Study
Takuya Yano, Masanori Yoshimitsu, Chiyomi Ishibashi, Atsuko Nishibara, Kanyu Nakano, Hitoshi Idani, Masazumi Okajima
Journal of the Anus, Rectum and Colon.2023; 7(4): 258. CrossRef - Intestinal Stomas—Current Practice and Challenges: An Institutional Review
Isam Mazin Juma, Tabarak Qassim, Mirza Faraz Saeed, Aya Qassim, Sana Al-Rawi, Sabrina Al-Salmi, Mustafa Thaer Salman, Ibrahim Al-Saadi, Abdulaziz Almutawea, Eman Aljahmi, Mohamed Khalid Fadhul
Euroasian journal of hepato-gastroenterology.2023; 13(2): 115. CrossRef - Preventing Anastomotic Leakage, a Devastating Complication of Colorectal Surgery
Hyun Gu Lee
The Ewha Medical Journal.2023;[Epub] CrossRef
Malignant disease,Colorectal cancer,Complication,Biomarker & risk factor
- Presepsin (soluble CD14 subtype) as a risk factor for the development of infectious and inflammatory complications in operated colorectal cancer patients
-
Kayrat Shakeyev, Yermek Turgunov, Alina Ogizbayeva, Olga Avdiyenko, Miras Mugazov, Sofiko Grigolashvili, Ilya Azizov
-
Ann Coloproctol. 2022;38(6):442-448. Published online April 4, 2022
-
DOI: https://doi.org/10.3393/ac.2022.00115.0016
-
-
3,995
View
-
132
Download
-
1
Web of Science
-
1
Citations
-
Abstract
PDF
- Purpose
In this pilot study the dynamic of presepsin (soluble CD14 subtype, sCD14-ST) in blood serum was assessed as a possible risk factor for the development of systemic inflammatory response syndrome (SIRS) and infectious and inflammatory complications in operated colorectal cancer patients.
Methods
To determine sCD14-ST by enzyme-linked immunosorbent assay method venous blood was taken 1 hour before surgery and 72 hours after it (3rd day). The presence of SIRS and organ dysfunctions (ODs) according to the Sequential Organ Failure Assessment scale were assessed.
Results
Thiry-six patients with colorectal cancer were enrolled in the study. sCD14-ST level before surgery was 269.8±103.1 pg/mL (interquartile range [IQR], 196.7–327.1 pg/mL). Despite the presepsin level on the 3rd day being higher (291.1±136.5 pg/mL; IQR, 181.2–395.5 pg/mL), there was no statistical significance in its dynamics (P=0.437). sCD14-ST value both before surgery and on the 3rd day after it was significantly higher in patients with bowel obstruction (P=0.038 and P=0.007). sCD14-ST level before surgery above 330 pg/mL showed an increase in the probability of complications, SIRS, and OD (odds ratio [OR], 5.5; 95% confidence interval [CI], 1.1–28.2; OR, 7.0; 95% CI, 1.3–36.7; and OR, 13.0; 95% CI, 1.1–147.8; respectively). Patients with OD had higher levels on the 3rd day after surgery (P=0.049).
Conclusion
sCD14-ST level in operated colorectal cancer patients was much higher if they were admitted with complication like bowel obstruction. Higher preoperative levels of sCD14-ST increase the probability of postoperative complications, SIRS, and OD. Therefore, further studies with large sample size are needed.
-
Citations
Citations to this article as recorded by

- Impact of Postoperative Naples Prognostic Score to Predict Survival in Patients with Stage II–III Colorectal Cancer
Su Hyeong Park, Hye Seung Woo, In Kyung Hong, Eun Jung Park
Cancers.2023; 15(20): 5098. CrossRef